News
A new study defines an epigenetic predisposition to suffer leukemia or lymphoma induced by the infection of the HTLV-1 virus
A study, with the participation of IDIBELL and ICO, published in Molecular Cancer, has described that people with epigenetic alterations in the FHIT tumor suppressor gene are more predisposed to developing the disease.
The pandemic has aggravated the symptoms of almost a third of patients with Obsessive-Compulsive Disorder (OCD)
A study led by IDIBELL and the Hospital de Bellvitge shows that during the lockdown, suicide thoughts were more frequent among people with OCD
Identified an early neuronal dysfunction in Parkinson’s that could help early diagnosis
Researchers from IDIBELL and the University of Barcelona (UB) have described that neurons derived from Parkinson’s patients show impairments in their transmission before neurodegeneration.
A nursing intervention increases the adherence to treatment after a heart attack in elderly patients
A study led by nursing professionals from the Bellvitge University Hospital and IDIBELL has shown that a specific nursing intervention achieves more adherence to treatment in complex elderly patients who have suffered a myocardial infarction.
Diets that promote inflammation can increase the risk of breast cancer by up to 12%
Research carried out by IDIBELL and ICO within the framework of the European EPIC study, which includes the monitoring of more than 350,000 women for 15 years, has determined the inflammatory potential of their diets with a new scoring system.
Two IDIBELL researchers receive support from the Mutua Madrileña Foundation
The Mutua Madrileña Foundation today gave its XVII Grants for Health Research to 27 research projects throughout Spain, 5 of them in Catalonia, of which 2 have been awarded to IDIBELL researchers.
Researchers from IDIBELL and Bellvitge University Hospital develop a new algorithm to predict sudden death and potentially lethal arrhythmias in some heart patients
Thanks to this new tool, it will be possible to determine more precisely the indication for an implantable defibrillator for high-risk patients
Jordi Adamuz receives the ICS nursing research career award
The Research Conference of the Catalan Health Institute 2020-2021, held today, June 28, has distinguished Dr. Jordi Adamuz with the ICS 2021 Nurse Research Career Award, endowed with € 10,000. Adamuz is a principal investigator at the IDIBELL nursing research group, and is currently a referral nurse in the Information Systems Support Unit of the Bellvitge University Hospital, and a research support nurse at the same institution.
“VacunAcció: how to immunize against misinformation” concludes its first edition
Vacunacció, the new initiative of the Escolab program with IDIBELL and the Virolai school, has ended this June with very original proposals.